Estrella Immunopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESLA and other ETFs, options, and stocks.

About ESLA

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.

CEO

Cheng Liu

CEOCheng Liu

Employees

—

Employees—

Headquarters

Emeryville, California

HeadquartersEmeryville, California

Founded

2022

Founded2022

Employees

—

Employees—

ESLA Key Statistics

Market cap

35.44M

Market cap35.44M

Price-Earnings ratio

-3.95

Price-Earnings ratio-3.95

Dividend yield

—

Dividend yield—

Average volume

117.69K

Average volume117.69K

High today

$1.04

High today$1.04

Low today

$0.9003

Low today$0.9003

Open price

$0.97

Open price$0.97

Volume

165.07K

Volume165.07K

52 Week high

$3.23

52 Week high$3.23

52 Week low

$0.63

52 Week low$0.63

Estrella Immunopharma

Why Robinhood?

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA. Show more

ESLA Key Statistics

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.